tiprankstipranks
Rasna Therapeutics Inc (RASP)
OTHER OTC:RASP
US Market

Rasna Therapeutics (RASP) Stock Price & Analysis

1 Followers

RASP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.01
Volume250.00
Average Volume (3M)117.00
Market Cap
$5.94M
Enterprise Value$6.15M
Total Cash (Recent Filing)$19.18K
Total Debt (Recent Filing)$225.70K
Price to Earnings (P/E)-1.6
Beta449.05
May 10, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding771,811,360
10 Day Avg. Volume0
30 Day Avg. Volume117
Standard Deviation16.22
R-Squared0.07
Alpha3.65
Financial Highlights & Ratios
Price to Book (P/B)-2.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-31.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda1.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

RASP FAQ

What was Rasna Therapeutics Inc’s price range in the past 12 months?
Rasna Therapeutics Inc lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
    What is Rasna Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Rasna Therapeutics Inc’s upcoming earnings report date?
    Rasna Therapeutics Inc’s upcoming earnings report date is May 10, 2018 which is 2168 days ago.
      How were Rasna Therapeutics Inc’s earnings last quarter?
      Currently, no data Available
      Is Rasna Therapeutics Inc overvalued?
      According to Wall Street analysts Rasna Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Rasna Therapeutics Inc pay dividends?
        Rasna Therapeutics Inc does not currently pay dividends.
        What is Rasna Therapeutics Inc’s EPS estimate?
        Rasna Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Rasna Therapeutics Inc have?
        Rasna Therapeutics Inc has 771,811,340 shares outstanding.
          What happened to Rasna Therapeutics Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Rasna Therapeutics Inc?
          Currently, no hedge funds are holding shares in RASP
          ---

          Rasna Therapeutics Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -56.79%
          Trailing 12-Months

          Company Description

          Rasna Therapeutics Inc

          Rasna Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Immutep
          Kezar Life Sciences
          Onconova Therapeutics
          Aileron Therapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis